(Q45219002)

10 December 2017

The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence (English)

1 reference

10 December 2017

Corinna Asang

1

1 reference

10 December 2017

Steffen Erkelenz

series ordinal

2

1 reference

10 December 2017

Heiner Schaal

series ordinal

3

1 reference

10 December 2017

language of work or name

English

0 references

publication date

30 June 2012

1 reference

10 December 2017

1 reference

10 December 2017

432

1 reference

10 December 2017

1

1 reference

10 December 2017

133-145

1 reference

RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

NMR structure of stem-loop SL2 of the HIV-1 psi RNA packaging signal reveals a novel A-U-A base-triple platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Purification of the individual snRNPs U1, U2, U5 and U4/U6 from HeLa cells and characterization of their protein constituents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

ESEfinder: A web resource to identify exonic splicing enhancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The yeast splicing factor Mud13p is a commitment complex component and corresponds to CBP20, the small subunit of the nuclear cap-binding complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A novel approach to describe a U1 snRNA binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Promoter proximal splice sites enhance transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A combinatorial code for splicing silencing: UAGG and GGGG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The strength of the HIV-1 3' splice sites affects Rev function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A nuclear cap-binding complex facilitates association of U1 snRNP with the cap-proximal 5' splice site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

SR proteins and related factors in alternative splicing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The SR protein family of splicing factors: master regulators of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Identification of the proteins of the yeast U1 small nuclear ribonucleoprotein complex by mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Human growth hormone as a reporter gene in regulation studies employing transient gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Frequent gain and loss of intronic splicing regulatory elements during the evolution of vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Splicing regulation: from a parts list of regulatory elements to an integrated splicing code

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Identification of eight proteins that cross-link to pre-mRNA in the yeast commitment complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Splicing of designer exons reveals unexpected complexity in pre-mRNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

A compensatory base change in U1 snRNA suppresses a 5' splice site mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

7 January 2021

The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

7 January 2021

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

7 January 2021

Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.004

7 January 2021

10.1016/J.VIROL.2012.06.004

Identifiers

DOI

1 reference

10 December 2017

1 reference